More News! 8 Feb 2019 Swiss Firm Launches Cancer Test That Gives Results in Minutes Lunaphore Technologies has launched a device for automated testing of cancer tissue samples that gives results in under 30 minutes. Lunaphore has developed a piece of next-generation equipment to perform immunohistochemistry (IHC) tests, a common technique used to find specific cancer biomarkers in tissue samples from cancer patients after a biopsy. The equipment, called LabSat, will […] February 8, 2019 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 4 Feb 2019 Swedish Biotech Receives EU Grant for High-Accuracy Kidney Cancer Test The Swedish biotech Elypta has received a Horizon 2020 grant of €2.4M to fund a clinical trial of a blood and urine test that provides an accurate diagnosis of renal cell carcinoma. The clinical trial aims to validate Elypta’s technology as a monitoring tool in patients who have been treated for the kidney cancer renal […] February 4, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Interview 13 Dec 2018 Making DNA Quantification More Precise Than Ever Technology advances are taking DNA quantification to a whole new level of precision by making it possible to identify single molecules in a sample. Philip talked to Rémi Dangla, CEO and co-founder of Stilla Technologies, to discuss advances and challenges in the field. Founded in 2013, Stilla Technologies is a French company that makes and […] December 13, 2018 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 20 Nov 2018 French Firm Gets Funding to Sell More Precise DNA Quantification System Paris-based Stilla Technologies has raised €16M in a Series A round to sell and develop a high-precision PCR system for DNA quantification with promising applications in diagnostics. The substantial round was led by Illumina Ventures, the investor arm of the gene sequencing giant Illumina. With the funds, Stilla Technologies plans to accelerate sales of its […] November 20, 2018 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 24 Oct 2018 15-Minute Cardiovascular Blood Test to Sell Across Europe French diagnostics company Magnisense has raised €5M to expand the sales of its emergency tests for heart attack and heart failure, which can be performed at home in just 15 minutes. The diagnostic technology developed by Magnisense, called MiAG, uses magnetic nanoparticles to detect extremely low quantities of cardiovascular biomarkers in the blood. “MiAG allows […] October 24, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
More News! 10 Oct 2018 This Test Can Detect Four Drugs With Just a Fingerprint The British company Intelligent Fingerprinting has shown that its non-invasive fingerprint drug test can yield results comparable to blood tests in just 10 minutes. The technology, developed at the University of East Anglia, can detect extremely low amounts of amphetamines, cannabis, cocaine and opiate drugs from the sweat of a single fingerprint. The sample is […] October 10, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 1 Oct 2018 Cancer-Sniffing Diagnostics Company Secures €43.1M Funding Intoxication is not the only condition that we could diagnose with breathalyzers. The UK-US company Owlstone Medical has secured €43.1M funding to help commercialize its tech that ‘smells’ cancer in your breath. Owlstone’s breathalyzer kit diagnoses conditions by measuring volatile organic compounds in a person’s breath. Disease pathologies affect the types and amounts of these […] October 1, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 22 Aug 2018 Swedish Biotech Breaks Barrier to Diagnosis with Rheumatoid Arthritis Test A blood test developed by Swedish-biotech Immunovia and scientists from Linköping University accurately diagnoses patients with rheumatoid arthritis even if they test negative for two common biomarkers. The current gold standard test for rheumatoid arthritis, which affects 5-7 million people in the US and Europe, misses a substantial number of people who have the condition. […] August 22, 2018 - 2 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
More News! 30 Jul 2018 We May Soon Diagnose Traumatic Brain Injury With a Single Drop of Blood Swiss and Spanish researchers are developing a diagnostic test that measures the severity of mild traumatic brain injury that delivers results in ten minutes with a single drop of blood. CT scans are currently the only reliable method for diagnosing mild traumatic brain injury. However, the technology is not available in all hospitals, is expensive […] July 30, 2018 - 3 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 23 Jul 2018 UK Biotech to Launch Rapid, Accurate HIV Test in Europe UK-biotech Owen Mumford plans to launch an HIV diagnostic test in Europe that can produce an accurate result within 15 minutes. Current rapid diagnostic tests for HIV can lead to misdiagnosis, for example when steps in the procedure are not followed in the right order, or too little blood is drawn. The new test, called […] July 23, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jul 2018 Radioactive Nanoparticle Could Improve Cancer Diagnoses Isotopia Molecular Imaging, an Israeli company, is developing a radioactive marker made of gold nanoparticles to detect cancer more accurately than with current diagnostic tools. PET and CT scans are two types of X-ray tests that use small quantities of radioactive materials, called contrast agents, to help visualize and assess organ and tissue function. These […] July 11, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Interview 3 Jul 2018 Fighting Antimicrobial Resistance with Fast Molecular Diagnostics Antimicrobial resistance is predicted to kill more people than cancer by 2050. Is it possible to prevent it? At our Refresh Meetup in Berlin, I talked with Achim Plum, CBO of the diagnostics company Curetis, about what are our best bets to turn the tables in the fight against the threat of antimicrobial resistance. The […] July 3, 2018 - 8 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email